CDEK
← All organizations

Taiho Pharmaceutical

For profit

Also known as: Taiho Oncology | TAIHO ONCOLOGY | Taiho Pharma Canada, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Aug 31, 2019

First marketed drug

Sep 22, 2015

Last known activity

Aug 31, 2019

Acquired by Otsuka on Jun 2, 1993

Timeline

1990s

  1. Jun 1, 1993

    Taiho Pharmaceutical— Founded

  2. Jun 2, 1993

    Otsuka— Acquired By

2020s

  1. Jul 7, 2020

    decitabine— NDA Secondary Org

  2. Sep 30, 2022

    futibatinib— Marketing Organization

Drugs by trial phase (2 distinct, 1 trials)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (5)

Recent trials (1)

Details

Founded
Tokyo, JP Jun 1, 1993
Last known activity
Aug 31, 2019